Breaking News, Promotions & Moves

Syner-G Biopharma Group Names Neil Butera Chief Commercial Officer

Brings depth and breadth of biotech experience to oversee continued company growth.

Syner-G BioPharma Group, a provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, appointed Neil Butera chief commercial officer. “We are thrilled to have Neil join the Syner-G team,” said Ron Kraus, CEO, Syner-G. “His proven commercial experience in the bio-tech industry is an invaluable asset to the current leadership team. We look forward to seeing the unique ways he will propel our services while contributing to our cu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters